Page last updated: 2024-09-04

gadolinium dtpa and carmustine

gadolinium dtpa has been researched along with carmustine in 2 studies

Compound Research Comparison

Studies (gadolinium dtpa)	Trials (gadolinium dtpa)	Recent Studies (post-2010) (gadolinium dtpa)	Studies (carmustine)	Trials (carmustine)	Recent Studies (post-2010) (carmustine)
12,654	664	4,051	4,168	686	540

Protein Interaction Comparison

Protein	Taxonomy	gadolinium dtpa (IC50)	carmustine (IC50)
Glutathione reductase, mitochondrial	Homo sapiens (human)		8.1

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Beattie, BJ; Blasberg, RG; Malkin, MG; Thiessen, B; Vlassenko, AG	1
Chen, PY; Chu, PC; Hua, MY; Huang, CY; Liu, HL; Pan, CH; Wang, JJ; Wei, KC; Yang, HW; Yen, TC	1

Other Studies

2 other study(ies) available for gadolinium dtpa and carmustine

Article	Year
Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI. Journal of neuro-oncology, 2000, Volume: 46, Issue:3 Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biological Transport, Active; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Disease-Free Survival; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioblastoma; Glucose; Humans; Isoxazoles; Leflunomide; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Platelet-Derived Growth Factor; Prognosis; Signal Transduction; Supratentorial Neoplasms; Tomography, Emission-Computed; Treatment Outcome	2000
Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology, 2010, Volume: 255, Issue:2 Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Carmustine; Chromatography, High Pressure Liquid; Contrast Media; Disease Progression; Feasibility Studies; Gadolinium DTPA; Glioblastoma; Magnetic Resonance Imaging; Proportional Hazards Models; Rats; Rats, Sprague-Dawley; Ultrasonic Therapy	2010

Article

Year

Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI.

Journal of neuro-oncology, 2000, Volume: 46, Issue:3

Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Biological Transport, Active; Carmustine; Chemotherapy, Adjuvant; Combined Modality Therapy; Cranial Irradiation; Disease Progression; Disease-Free Survival; Energy Metabolism; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Glioblastoma; Glucose; Humans; Isoxazoles; Leflunomide; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Platelet-Derived Growth Factor; Prognosis; Signal Transduction; Supratentorial Neoplasms; Tomography, Emission-Computed; Treatment Outcome

2000

Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment.

Radiology, 2010, Volume: 255, Issue:2

Topics: Animals; Blood-Brain Barrier; Brain Neoplasms; Carmustine; Chromatography, High Pressure Liquid; Contrast Media; Disease Progression; Feasibility Studies; Gadolinium DTPA; Glioblastoma; Magnetic Resonance Imaging; Proportional Hazards Models; Rats; Rats, Sprague-Dawley; Ultrasonic Therapy

2010